Market Place
Sourcing Support
Kyzatrex Featured In Research At SMSNA Fall Scientific Meeting
16 Oct 2024 //
GLOBENEWSWIRE
nuBioAge, nuHx, Marius Team Up For GLP-1 Comparison Study
25 Sep 2024 //
PR NEWSWIRE
Marius PharmaPartners With Numan For Kyzatrex Distribution
18 Sep 2024 //
GLOBENEWSWIRE
WellSync-Marius Offer FDA-Approved Oral Testosterone Replacement Therapy
09 Sep 2024 //
PR NEWSWIRE
Vitamin Shoppe Expands Telehealth with Testosterone Therapy via KYZATREX
03 Sep 2024 //
PR NEWSWIRE
Marius Pharmaceuticals Submits KYZATREX® For Health Canada Approval
30 Jul 2024 //
GLOBENEWSWIRE
Marius Publishes Phase 3 KYZATREX® Testosterone Data
11 Apr 2024 //
PR NEWSWIRE
Marius Announces Study Exploring the Effect of Therapy, KYZATREX
09 Jan 2024 //
PR NEWSWIRE
Marius pitches low T drug as helping men find their inner hero
08 Dec 2023 //
FIERCE PHARMA
Marius Pharmaceuticals Announces KYZATREX HERO Campaign
06 Dec 2023 //
PR NEWSWIRE
Marius Pharmaceuticals Expands Access of KYZATREX to Department of VA
19 Sep 2023 //
GLOBENEWSWIRE
Marius Partners with Smartway to Design Early Access Program for KYZATREX
10 Aug 2023 //
GLOBENEWSWIRE
Marius Pharmaceuticals Announces Launch of ReThink Testosterone for Patients
24 Jul 2023 //
GLOBENEWSWIRE
Marius Pharma Supports AXYS 2023 Virtual Family Conference, KYZATREX
20 Jun 2023 //
GLOBENEWSWIRE
Marius Pharma Announces Two Key Patents Related to KYZATREX„¢ in FDA Orange Book
09 Jun 2023 //
GLOBENEWSWIRE
CORRECTION -- Marius Pharmaceuticals Receives FDA Approval of KYZATREX™
21 Sep 2022 //
GLOBENEWSWIRE
Marius Pharmaceuticals Receives FDA Approval of KYZATREX
02 Aug 2022 //
GLOBENEWSWIRE
Marius Receives PDUFA Date for KYZATREX® NDA for Hypogonadism
11 Mar 2021 //
GLOBENEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.